Composition
- Active ingredients
- VORAPAXAR SULFATE EQ 2.08MG BASE
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA204886.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Zontivity
- Active substance
- vorapaxar sulfate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Key Therap
- Status
- Discontinued
- FDA approval
- 8 May 2014
- Application
- NDA204886-001